Ligand profile
3QP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3030 — tyrosine aminotransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
3QP- PDB
3qpg- UniProt (similar protein)
P00509- Target protein
- VK055_3030
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 173.9
- −1 ≤ LogP ≤ 5 0.66
- MW ≤ 500 Da 361.2
- LogP ≤ 5 0.66
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 173.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(c(c1O)/C=N/[C@@H](CC(=O)O)C(=O)O)COP(=O)(O)OCc1ccc(c(c1O)/C=N/[C@@H](CC(=O)O)C(=O)O)COP(=O)(O)O
InChI=1S/C13H16NO9P/c1-7-2-3-8(6-23-24(20,21)22)9(12(7)17)5-14-10(13(18)19)4-11(15)16/h2-3,5,10,17H,4,6H2,1H3,(H,15,16)(H,18,19)(H2,20,21,22)/b14-5+/t10-/m0/s1InChI=1S/C13H16NO9P/c1-7-2-3-8(6-23-24(20,21)22)9(12(7)17)5-14-10(13(18)19)4-11(15)16/h2-3,5,10,17H,4,6H2,1H3,(H,15,16)(H,18,19)(H2,20,21,22)/b14-5+/t10-/m0/s1
CMDDKMGWJXISQE-ZFGNZVLRSA-NCMDDKMGWJXISQE-ZFGNZVLRSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00155
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 3QP →
- PDB RCSB structure 3qpg →
- UniProt UniProt P00509 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “3QP”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3030.
PDB 30
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).